CVS Health Corp.

The current price of CVS is $83.60 — it has increased by 2.79% since the previous close. Data as of Nov 6, 2026.

CVS is down 9.08% over the past week, down 3.27% over the past month and up 6.28% over the past year. The price is below its 200-day moving average of $88.89.

Analysts' average 12-month price target for CVS is $110.83, which implies 32.57% upside from the current price. Individual estimates range from $92.00 to $123.00.

Of the 27 analysts covering CVS Health Corp., 7 rate it a strong buy, 18 rate it a buy and 2 rate it a hold. The overall consensus is bullish. Analyst ratings are opinions and do not guarantee future performance.

CVS Health Corp. has a market capitalization of $106.92B. The company belongs to the Healthcare sector. Compare it with other companies in the stock screener.

In its most recent quarterly report, CVS Health Corp. posted earnings of $2.09 per share against an estimate of $1.65, beating expectations by 26.67%. Upcoming reports are listed in the earnings calendar.

CVS Health Corp. reported revenue of $108.4B in its most recent quarter, which has increased by 5.37% compared with the same quarter a year earlier. Analysts had expected $104.72B.

Yes. CVS Health Corp. pays dividends quarterly. The latest payment of $0.665 per share has a payment date of Nov 2, 2026, which corresponds to a dividend yield of 2.82%.

Companies most comparable to CVS Health Corp. include UnitedHealth Group Incorporated, Elevance Health Inc., Cigna Corporation, Humana Inc. and Centene Corp.

In the latest trading session CVS moved between $80.69 and $84.37, a range of 4.40% of its current price.

Over the past 52 weeks CVS has traded between $69.51 and $110.68. The current price is 24.47% below its 52-week high.